216 related articles for article (PubMed ID: 2460958)
1. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
[TBL] [Abstract][Full Text] [Related]
2. Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with Sandostatin.
Mozell EJ; Woltering EA; O'Dorisio TM; Phillipson BE; Fletcher J; Fletcher WS; Howe B; Hill D; Rhea D
Am J Gastroenterol; 1990 Feb; 85(2):181-8. PubMed ID: 2405644
[TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
Williams G; Anderson JV; Williams SJ; Bloom SR
Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
[TBL] [Abstract][Full Text] [Related]
5. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
[TBL] [Abstract][Full Text] [Related]
6. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors.
Wynick D; Williams SJ; Bloom SR
N Engl J Med; 1988 Sep; 319(10):605-7. PubMed ID: 2842676
[TBL] [Abstract][Full Text] [Related]
8. Surgical experience with functioning pancreatic neuroendocrine tumors.
Matthews BD; Smith TI; Kercher KW; Holder WD; Heniford BT
Am Surg; 2002 Aug; 68(8):660-5; discussion 665-6. PubMed ID: 12206598
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analogue (SMS 201-995) in patients with gastrinomas.
Vinik AI; Tsai S; Moattari AR; Cheung P
Surgery; 1988 Nov; 104(5):834-42. PubMed ID: 2903562
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
Arnold R; Neuhaus C; Trautmann ME
Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
[No Abstract] [Full Text] [Related]
11. Somatostatin analog: effects on hypergastrinemia and hypercalcitoninemia.
Geelhoed GW; Bass BL; Mertz SL; Becker KL
Surgery; 1986 Dec; 100(6):962-70. PubMed ID: 2431492
[TBL] [Abstract][Full Text] [Related]
12. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
Maton PN; Gardner JD; Jensen RT
Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Rehfeld JF
Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
[TBL] [Abstract][Full Text] [Related]
15. Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis.
Tsai ST; Eckhauser FE; Thompson NW; Strodel WE; Vinik AI
Surgery; 1986 Oct; 100(4):788-95. PubMed ID: 2876529
[TBL] [Abstract][Full Text] [Related]
16. [Peptide-producing tumors in the pancreas and gastrointestinal tract: syndrome, survey, therapy].
Hemmingson A; Johansson H; Lindgren PG; Lundqvist G; Lörelius LE; Wide L; Wilander E; Oberg K
Lakartidningen; 1984 Aug; 81(35):3015-21. PubMed ID: 6147450
[No Abstract] [Full Text] [Related]
17. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
Glaser B; Rösler A; Halperin Y
Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
[TBL] [Abstract][Full Text] [Related]
18. Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome.
Chiang HC; O'Dorisio TM; Huang SC; Maton PN; Gardner JD; Jensen RT
Gastroenterology; 1990 Dec; 99(6):1565-75. PubMed ID: 2227272
[TBL] [Abstract][Full Text] [Related]
19. [Somatostatin analogue in the treatment of neuroendocrine gut tumors].
Ben Yosef R; Glaser B; Catane R
Harefuah; 1990 Jul; 119(1-2):15-8. PubMed ID: 2172125
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Moattari AR; Cho K; Vinik AI
Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]